| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |